46. Malignant rheumatoid arthritis Clinical trials / Disease details
Clinical trials : 4,356 / Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00482417 (ClinicalTrials.gov) | December 2002 | 1/6/2007 | Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017) | Rheumatoid Arthritis | Drug: MK0359 | Merck Sharp & Dohme Corp. | NULL | Completed | 18 Years | 65 Years | Both | 11 | Phase 2 | NULL |